How melanoma can resist newly approved drug combo therapy
Thursday, January 15, 2015 - 13:30
in Health & Medicine
Researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.